Report Detail
Global (United States, European Union and China) Sodium Valproate Market Research Report 2019-2025
- RnM3685446 |
- 20 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
In 2019, the market size of Sodium Valproate is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sodium Valproate.
This report studies the global market size of Sodium Valproate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Sodium Valproate sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
sanofi-aventis
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Market Segment by Product Type
Injection
Tablet
Liquid
Market Segment by Application
Epilepsy
Migraines
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Sodium Valproate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Sodium Valproate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Sodium Valproate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Sodium Valproate Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Injection
- 1.3.3 Tablet
- 1.3.4 Liquid
- 1.4 Market Segment by Application
- 1.4.1 Global Sodium Valproate Market Share by Application (2019-2025)
- 1.4.2 Epilepsy
- 1.4.3 Migraines
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Sodium Valproate Market Size
- 2.1.1 Global Sodium Valproate Revenue 2014-2025
- 2.1.2 Global Sodium Valproate Sales 2014-2025
- 2.2 Sodium Valproate Growth Rate by Regions
- 2.2.1 Global Sodium Valproate Sales by Regions 2014-2019
- 2.2.2 Global Sodium Valproate Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Sodium Valproate Sales by Manufacturers
- 3.1.1 Sodium Valproate Sales by Manufacturers 2014-2019
- 3.1.2 Sodium Valproate Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Sodium Valproate Revenue by Manufacturers (2014-2019)
- 3.2.2 Sodium Valproate Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Sodium Valproate Market Concentration Ratio (CR5 and HHI)
- 3.3 Sodium Valproate Price by Manufacturers
- 3.4 Key Manufacturers Sodium Valproate Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Sodium Valproate Market
- 3.6 Key Manufacturers Sodium Valproate Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Injection Sales and Revenue (2014-2019)
- 4.1.2 Tablet Sales and Revenue (2014-2019)
- 4.1.3 Liquid Sales and Revenue (2014-2019)
- 4.2 Global Sodium Valproate Sales Market Share by Type
- 4.3 Global Sodium Valproate Revenue Market Share by Type
- 4.4 Sodium Valproate Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Sodium Valproate Sales by Application
6 United States
- 6.1 United States Sodium Valproate Breakdown Data by Company
- 6.2 United States Sodium Valproate Breakdown Data by Type
- 6.3 United States Sodium Valproate Breakdown Data by Application
7 European Union
- 7.1 European Union Sodium Valproate Breakdown Data by Company
- 7.2 European Union Sodium Valproate Breakdown Data by Type
- 7.3 European Union Sodium Valproate Breakdown Data by Application
8 China
- 8.1 China Sodium Valproate Breakdown Data by Company
- 8.2 China Sodium Valproate Breakdown Data by Type
- 8.3 China Sodium Valproate Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Sodium Valproate Breakdown Data by Company
- 9.2 Rest of World Sodium Valproate Breakdown Data by Type
- 9.3 Rest of World Sodium Valproate Breakdown Data by Application
- 9.4 Rest of World Sodium Valproate Breakdown Data by Countries
- 9.4.1 Rest of World Sodium Valproate Sales by Countries
- 9.4.2 Rest of World Sodium Valproate Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 sanofi-aventis
- 10.1.1 sanofi-aventis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.1.4 Sodium Valproate Product Introduction
- 10.1.5 sanofi-aventis Recent Development
- 10.2 AbbVie
- 10.2.1 AbbVie Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.2.4 Sodium Valproate Product Introduction
- 10.2.5 AbbVie Recent Development
- 10.3 Athenex
- 10.3.1 Athenex Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.3.4 Sodium Valproate Product Introduction
- 10.3.5 Athenex Recent Development
- 10.4 Fresenius Kabi
- 10.4.1 Fresenius Kabi Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.4.4 Sodium Valproate Product Introduction
- 10.4.5 Fresenius Kabi Recent Development
- 10.5 Hikma Farmaceutica
- 10.5.1 Hikma Farmaceutica Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.5.4 Sodium Valproate Product Introduction
- 10.5.5 Hikma Farmaceutica Recent Development
- 10.6 Desitin Pharmaceuticals
- 10.6.1 Desitin Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.6.4 Sodium Valproate Product Introduction
- 10.6.5 Desitin Pharmaceuticals Recent Development
- 10.7 Wockhardt
- 10.7.1 Wockhardt Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.7.4 Sodium Valproate Product Introduction
- 10.7.5 Wockhardt Recent Development
- 10.8 Zentiva
- 10.8.1 Zentiva Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Sodium Valproate
- 10.8.4 Sodium Valproate Product Introduction
- 10.8.5 Zentiva Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Sodium Valproate Sales Channels
- 11.2.2 Sodium Valproate Distributors
- 11.3 Sodium Valproate Customers
12 Market Forecast
- 12.1 Global Sodium Valproate Sales and Revenue Forecast 2019-2025
- 12.2 Global Sodium Valproate Sales Forecast by Type
- 12.3 Global Sodium Valproate Sales Forecast by Application
- 12.4 Sodium Valproate Forecast by Regions
- 12.4.1 Global Sodium Valproate Sales Forecast by Regions 2019-2025
- 12.4.2 Global Sodium Valproate Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Sodium Valproate. Industry analysis & Market Report on Sodium Valproate is a syndicated market report, published as Global (United States, European Union and China) Sodium Valproate Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Sodium Valproate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
